Regennass Lucie, Brulefert Kevin, Feuillet Fanny, Nich Christophe
Nantes Université, CHU Nantes, Clinique Chirurgicale Orthopédique Et Traumatologique, 44000 Nantes, France.
INSERM, SPHERE U1246, Nantes Université, Université de Tours, Nantes, France.
Indian J Orthop. 2023 Jan 27;57(3):436-444. doi: 10.1007/s43465-023-00816-7. eCollection 2023 Mar.
We hypothesized the risk of prosthetic instability would be similar in patients treated for femoral neck fracture (FNF) comparatively to patients treated for osteoarthritis (OA) using a dual-mobility cup-total hip arthroplasty (DMC-THA).
One hundred and nine patients (109 hips), with a mean age of 69.6 ± 3 years (65-75 years), underwent DMC-THA using a posterolateral approach for a FNF (study group). Patients were matched for age and sex with 109 OA patients treated by the same procedure (control).
Postoperatively, there were four dislocations of the large articulation in the study group, and none in the control ( = 0.12). Periprosthetic joint infection (PJI) was the most common surgical complication and was more frequent in the study group. Postoperatively, functional results were at least good in > 90% patients in both groups. At the last follow-up, patients in the study group had recovered autonomy and physical activity comparable to those of the preoperative period.
We found no increased risk of dislocation after DMC-THA using a posterolateral approach for FNF as compared to the same procedure for OA. In this study, function and independence were restored postoperatively in the vast majority of patients. DMC-THA appears as a viable therapeutic option in autonomous patients with a displaced FNF.
我们推测,与采用双动杯全髋关节置换术(DMC-THA)治疗骨关节炎(OA)的患者相比,股骨颈骨折(FNF)患者发生假体不稳定的风险相似。
109例患者(109髋),平均年龄69.6±3岁(65 - 75岁),采用后外侧入路行DMC-THA治疗FNF(研究组)。按照年龄和性别将这些患者与109例接受相同手术治疗的OA患者进行匹配(对照组)。
术后,研究组发生4例大关节脱位,对照组无脱位发生(P = 0.12)。假体周围关节感染(PJI)是最常见的手术并发症,且在研究组中更频繁。术后,两组超过90%的患者功能结果至少为良好。在最后一次随访时,研究组患者恢复了与术前相当的自主性和身体活动能力。
我们发现,与OA患者采用相同手术相比,采用后外侧入路行DMC-THA治疗FNF后脱位风险并未增加。在本研究中,绝大多数患者术后功能和独立性得以恢复。DMC-THA似乎是适合自主活动的移位FNF患者的一种可行治疗选择。